Brain Research Bulletin
March 11, 2016
Elisabet Domínguez‐clavé, Joaquim Soler, Matilde Elices et al.
220 citations
Ayahuasca, a tea made from the vine Banisteriopsis caapi and often combined with Psychotria viridis leaves, induces a transient altered state of consciousness marked by introspection, visions, enhanced emotions, and personal memory recall. Its psychoactive effects come from N,N-dimethyltryptamine (DMT), a 5-HT2A receptor agonist, and β-carboline alkaloids that inhibit monoamine oxidase. A growing body of evidence suggests ayahuasca may help treat substance use disorders, anxiety, and depression. The review discusses how ayahuasca intake increases mindfulness facets related to acceptance and detached observation of thoughts and emotions. The authors conclude ayahuasca shows promise for enhancing self-acceptance and enabling safe exposure to emotional events, potentially useful for impulse-related, personality, and substance use disorders and trauma, though more research is needed.
Psychopharmacology
November 27, 2015
Joaquim Soler, Matilde Elices, Alba Franquesa et al.
212 citations
Ayahuasca, a psychotropic plant tea containing DMT and β-carboline alkaloids, increases mindfulness capacities within 24 hours of a single session. In 25 individuals, ayahuasca significantly reduced judgmental processing of experiences and inner reactivity, as measured by the Five Facets Mindfulness Questionnaire, and increased decentering ability, as measured by the Experiences Questionnaire. These changes match those seen after extensive mindfulness practice and support the tea's therapeutic potential, particularly for addiction and depression.
The International Journal of Neuropsychopharmacology
May 17, 2017
Frederic Sampedro, Mario de la Fuente Revenga, Marta Valle et al.
205 citations
A single dose of ayahuasca reduced glutamate+glutamine, creatine, and N-acetylaspartate+N-acetylaspartylglutamate in the posterior cingulate cortex of 16 healthy volunteers, measured post-acutely with magnetic resonance spectroscopy. Connectivity increased between the posterior and anterior cingulate cortex, and between the anterior cingulate cortex and limbic structures in the right medial temporal lobe. Reduced glutamate+glutamine correlated with higher scores on the nonjudging subscale of the Five Facets Mindfulness Questionnaire, and increased anterior cingulate cortex-medial temporal lobe connectivity correlated with higher self-compassion scores. Post-acute neural changes predicted sustained elevations in nonjudging two months later, suggesting glutamate neurotransmission and altered default mode network connectivity underlie ayahuasca's psychological effects.
European Neuropsychopharmacology
March 26, 2016
Marta Valle, Ana Maqueda, Mireia Rabella et al.
175 citations
Ayahuasca, a psychoactive Amazonian tea, contains DMT and other compounds. In a double-blind, placebo-controlled study with 12 experienced users, ayahuasca reduced brain oscillations in delta, theta, and alpha frequency bands. The intensity of visual imagery correlated inversely with alpha-band current density in parietal and occipital cortex. Pretreatment with the 5-HT2A antagonist ketanserin blocked these neurophysiological changes, weakened the correlation between alpha activity and visual effects, and reduced subjective intensity. These results indicate that activation of the 5-HT2A receptor is central to ayahuasca's neurophysiological and visual effects in humans, despite the tea's chemical complexity.